Skip to main content
Log in

Elastase from polymorphonuclear leukocyte in articular cartilage and synovial fluids of patients with rheumatoid arthritis

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Objective was to study the significance and the mechanism of action of elastase from polymorphonuclear leukocyte (PMN elastase) in patients with rheumatoid arthritis (RA). The experiments conducted consisted of two phases. Firstly, articular cartilage and synovia from 8 patients with RA undergoing total knee replacement were obtained, and the gelatinolytic enzyme activity was extracted with 2M guanidine hydrochloride. The gelatinolytic activity of each tissue was measured to confirm that the activity was due to PMN elastase by using an antihuman leukocyte elastase antibody. Secondly, the levels of PMN elastase-α1 proteinase inhibitor complex (EIC) in the blood and synovial fluid of 170 patients with RA were measured by immunoassay. The results were as follows: 1. Gelatinolitic activity was shown to be mainly due to PMN elastase, and found to be highest in cartilage and synovia in RA joints. 2. The EIC levels in plasma of RA patients were significantly higher than those in gout and osteoarthritis (OA), and the EIC levels increased according to the stage of articular cartilage destruction. Moreover, the EIC levels in synovial fluid of RA patients were higher compared to those of OA patients. The activity of PMN elastase was elevated in destructive joints of RA. With the progression of articular cartilage destruction, EIC levels in plasma of RA patients increased as well. We suggest that PMN elastase may play a significant role in RA disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Martel-Pelletier J, Cloutier JM, Howell DS, Pelletier JP. Human rheumatoid arthritic cartilage and its neutral proteoglycan-degrading proteases. The effets of antirheumatic drugs. Arthritis Rheum 1985; 28: 405–12.

    PubMed  Google Scholar 

  2. Peltonen L, Puranen J, Lehtinen K, Korhonen LK. Proteolytic enzymes in joint destruction. Scand J Rheumatol 1981; 10: 107–14.

    PubMed  Google Scholar 

  3. Menniner H, Pulzier R, Mohr W, Wessinghage D, Tillmann K. Granulocyte elastase at the site of cartilage erosion by rheumatoid synovial tissue. Z Rheumatol 1980; 39: 145–56.

    PubMed  Google Scholar 

  4. Velvart M, Fehr K. Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes. Rheumatol Int 1987; 7: 195–202.

    Article  PubMed  Google Scholar 

  5. Adeyemi EO, Campos LB, Loizou S, Walport MJ, Hodgson HJF. Plasma lactoferrin and neutrophil elastase in rheumatoid arthritis and systemic lupus erythematosus. Br J Rheumatol 1990; 29: 15–20.

    PubMed  Google Scholar 

  6. Currie MS, Vala M, Pisetsky DS, Greenberg CS, Crawford J, Cohen HJ. Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders. Blood 1990; 75: 1699–1704.

    PubMed  Google Scholar 

  7. Watorek W. Farley D, Salvesen G, Travis J. Neutrophil elastase and cathepsin G: structure, function, and biological control. Adv Exp Med Biol 1988; 240: 23–31.

    PubMed  Google Scholar 

  8. Salvesen G, Enghlid JJ. Zymogen activation specificity and genomic structures of human neutrophil elastase and cathepsin G reveal a new branch of the chymotrypsinogen superfamily of serine proteinases. Biomed Biochim Acta 1991; 50: 665–71.

    PubMed  Google Scholar 

  9. Watanabe H, Hattori S, Katsuda S, Nakanishi I, Nagai Y. Human neutrophil elastase: Degradation of basement membrane components and immunolocalization in the tissue. J. Biochem 1990; 108: 753–59.

    PubMed  Google Scholar 

  10. Breta U, Baggidini M. Biomedical and morphological characterization of azurophil and specific granules of human neutrophilic polymorphonuclear leukocytes. J Cell Bio 1974; 63: 251–69.

    Article  Google Scholar 

  11. Fujita K, Nakagawa T, Hirabayashi K, Nagai Y. Neutral proteinases in human intervertebral disc. Spine 1993; 18: 1766–73.

    PubMed  Google Scholar 

  12. Nakagawa T, Gosh P, Magai Y. Serine proteinases and serine proteinaes inhibitors of normal and degenerate knee joint menisci. Biomed Res 1983; 4: 25–32.

    Google Scholar 

  13. Yamada H, Nakagawa T, Stephens RW, Nagai Y. Proteinases and their inhibitors in normal and osteoarthritic articular cartilage. Biomed Res 1987; 8: 289–300.

    Google Scholar 

  14. Sunada H, Nagai Y. A rapid microassay method for gelatinolytic activity using tritium-labeled heat-denatured polymeric collagen as a substrate and its application to the detection of enzymes involved in collagen metabolism. J Biochem 1980; 87: 1765–71.

    PubMed  Google Scholar 

  15. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980; 102: 196–202.

    Article  PubMed  Google Scholar 

  16. Neumann S, Gunzer G, Hennrich N, Lang H. “PMN-Elastase Assay”: Enzyme immunoassay for human polymorphonuclear elastase complexed with α1-proteinase inhibitor. J Clin Chem Clin Biochem 1984; 22: 693–7.

    PubMed  Google Scholar 

  17. Gressner AM, Peltzer B. Amidolytic and immunonephelometric determination of alpha 1-proteinase inhibitor and alpha 2macroglobulin in serum with calculation of specific inhibitor activities in health and disease. J Clin Chem Clin Biochem 1984; 22: 633–40.

    PubMed  Google Scholar 

  18. Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, Shinmei M, Hayakawa T. Human matrix metalloproteinase-3 (stromelysin-1) using monoclonal antibodies. Clinica Chimica Acta 1992; 211: 59–72.

    Article  Google Scholar 

  19. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Method 1990; 127: 103–108.

    Article  Google Scholar 

  20. Martel-Pelletier J, Pelletier JP. Neutral proteases in human osteoarthritic synovium. J Rheumatol (supple 14) 1987; 14: 38–40.

    PubMed  Google Scholar 

  21. Okada H, Nagase H, Harris ED. Matrix metalloproteinases 1,2 and 3 from rheumatoid synovial cells are sufficient to destroy joints. J Rheumatol (suppl 14) 1987; 14: 41–2.

    PubMed  Google Scholar 

  22. Nagase H, Enghild JJ, Suzuki K, Salvesen G. Stepwise activation mechanismus of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochem 1990; 29: 5783–9.

    Article  Google Scholar 

  23. Campbell IK, Piccoli DS, Butler DM, Singleton DK, Hamilton JA. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator. Biochim Biophys Acta 1988; 967: 183–94.

    PubMed  Google Scholar 

  24. Okada Y, Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (‘gelatinase’) by human neutrophil elastase and cathepsin G. FEBS Lett. 1989; 249: 353–6.

    Article  PubMed  Google Scholar 

  25. Noyori K, Koshino T, Takagi T, Okamoto R, Jasin HE. Binding characteristics of antitype II collagen antibody to the surface of diseased human cartilage as a probe for tissue damage. J Rheumatol 1994; 21: 293–6.

    PubMed  Google Scholar 

  26. Blackburn WD, Koopman WJ, Schlohenlother RE, Heck LW. Induction of neutrophil enzyme release by rheumatoid factors: evidence for differences based on molecular characteristics. Clin Immunol Immunopathol 1986; 40: 347–55.

    Article  PubMed  Google Scholar 

  27. Hasty Ka, Reife RA. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990; 33: 388–97.

    PubMed  Google Scholar 

  28. Causton TE, Mercer E, De Silva M, Hazleman BL. Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum 1984; 27: 285–90.

    PubMed  Google Scholar 

  29. Hayakawa T, Yamashita K, Kodama S, Iwata H, Iwata K. Tissue inhibitor of metalloproteinases and collagenase activity in synovial fluid of human rheumatoid arthritis. Biomed Res 1991; 12: 169–73.

    Google Scholar 

  30. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993; 36: 372–9.

    PubMed  Google Scholar 

  31. Okada Y, Watanabe S, Nakanishi I, Kishi J, Hayakawa T, Watorek W, Travis J, Nagase H. Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 1988; 229: 157–60.

    Article  PubMed  Google Scholar 

  32. Perlmutter DH, Joslin G, Nelson P, Schasteen C, Adams SP, Fallon RJ. Endocytosis and degradation of α1-antitrypsin-protease complexes is mediated by the serpinenzyme complex (SEC) receptor. J Biol Chem 1990; 265: 16713–6.

    PubMed  Google Scholar 

  33. Barrett AJ. The possible role of neutrophil proteinases in damage to articular cartilage. Agents Actions 1978; 8: 11–8.

    Article  PubMed  Google Scholar 

  34. Brown KA. The polymorphonuclear cell rheumatoid arthritis. Br J Rheumatol 1988; 27: 150–5.

    Google Scholar 

  35. Moroz LA, Wing S, Liote F. Mini-plasminogen-like fragments of plasminogen in synovial fluid in acute inflammatory arthritis. Thromb Res 1986; 43: 417–24.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Momohara, S., Kashiwazaki, S., Inoue, K. et al. Elastase from polymorphonuclear leukocyte in articular cartilage and synovial fluids of patients with rheumatoid arthritis. Clin Rheumatol 16, 133–139 (1997). https://doi.org/10.1007/BF02247841

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02247841

Key words

Navigation